← Database
Synthetic Peptide

TB-500

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

Most evidence is preclinical. Human clinical data are limited; not an approved therapeutic.

How it works

TB-500 is a synthetic fragment related to Thymosin β4, a natural protein that helps organize the cell's internal scaffolding (the actin cytoskeleton).

Through its connection to actin regulation, the parent protein is involved in cell movement, blood-vessel formation, and dampening inflammation — and in animal models TB-500 has been linked to improved healing of muscle, tendon, and other tissue. Those are the mechanisms behind its use in recovery contexts.

As with BPC-157, the evidence base is largely preclinical. Some early human work exists on the parent protein, but TB-500 itself lacks adequate controlled human trials and is not an approved therapeutic.

Mechanism · Detailed Analysis
Molecular targetA synthetic fragment of Thymosin β4, an actin-sequestering protein.
Proposed downstream effectsRegulation of actin polymerisation linked to cell migration, angiogenesis, and reduced inflammation in repair models.
Evidence & caveatsMechanistic claims come from preclinical work; TB-500 itself lacks adequate controlled human data.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.